- 1201. Conjunctival Ecchymosis
- (UMLS (NCI) C0858917) =Finding
| - 1251. CONPADRI-I
- (UMLS (NCI) C0279326) =Therapeutic or Preventive Procedure
|
- 1202. Conjunctival edema
- (UMLS (ICD9CM) C0151601) =Finding
| - 1252. CONSANGUINITY
- (UMLS (ICD9CM) C0015584) =Finding
|
- 1203. Conjunctival Epithelium
- (UMLS (NCI) C1179037) =Tissue ;
| - 1253. conscience
- [The cognitive and affective processes which constitute an internalized moral governor over an individual's moral conduct. ( MSH )] (UMLS (CSP) C0009790) =Mental Process
|
- 1204. Conjunctival Granuloma
- (UMLS (NCI) C0155165) =Disease or Syndrome ;
| - 1254. Conscious
- [state of being aware, or perceiving physical facts or mental concepts; a state of general wakefulness and responsiveness to environment; a functioning sensorium. ( CSP )] (UMLS (NCI) C0234421) =Mental Process =cognition;
|
- 1205. Conjunctival hemorrhage
- (UMLS (ICD9CM) C0009760) =Pathologic Function ;
| - 1255. Consensus
- [Agreement as the result of multiple results or opinions. ( NCI )] (UMLS (NCI) C0376298) =Social Behavior
|
- 1206. Conjunctival Injury
- (UMLS (NCI) C0339174) =Injury or Poisoning ;
| - 1256. Consensus Sequence
- [A sequence pattern derived from the alignment of multiple sequences that represents the nucleotide or amino acid most likely to occur at each position in a sequence. (Drug Discovery & Development, www.dddmag.com glossary) ( NCI )] (UMLS (NCI) C0079160) =Nucleotide Sequence ;
|
- 1207. Conjunctival Kaposi Sarcoma
- [A Kaposi sarcoma arising from the conjunctiva. ( NCI )] (UMLS (NCI) C0346935) =Neoplastic Process
| - 1257. consent
- [The Consent class represents informed consents and all similar medico-legal transactions between the patient (or his legal guardian) and the provider. Examples are informed consent for surgical procedures, informed consent for clinical trials, advanced beneficiary notice, against medical advice decline from service, release of information agreement, etc.The details of consents vary. Often an institution has a number of different consent forms for various purposes, including reminding the physician about the topics to mention. Such forms also include patient education material. In electronic medical record communication, consents thus are information-generating acts on their own and need to be managed similar to medical activities. Thus, Consent is modeled as a special class of Act.The "signatures" to the consent document are represented electronically through Participation instances to the consent object. Typically an informed consent has Participation.typeCode of "performer", the healthcare provider informing the patient, and "consenter", the patient or legal guardian. Some consent may associate a witness or a notary public (e.g., living wills, advanced directives). In consents where a healthcare provider is not required (e.g. living will), the performer may be the patient himself or a notary public.Some consent has a minimum required delay between the consent and the service, so as to allow the patient to rethink his decisions. This minimum delay can be expressed in the act definition by the ActRelationship.pauseQuantity attribute that delays the service until the pause time has elapsed after the consent has been completed. ( HL7V3.0 )] (UMLS (HL7) C1554192) =Idea or Concept =act;
|
- 1208. Conjunctival Nevus
- (UMLS (NCI) C0346363) =Neoplastic Process
| - 1258. Consent Bypass Reason
- (UMLS (HL7) C1547874) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Professional Judgment;
Emergency;
|
- 1209. CONJUNCTIVAL OP NEC
- (UMLS (ICD9CM) C0175568) =Therapeutic or Preventive Procedure
| - 1259. Consent Code
- (UMLS (HL7) C1550354) =Idea or Concept =HL7 Vocabulary Version 2.5;
|
- 1210. Conjunctival scars
- [ ] (UMLS (ICD9CM) C0155164) =Acquired Abnormality ;
| - 1260. Consent Disclosure Level
- (UMLS (HL7) C1547875) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Full Disclosure;
No Disclosure;
Partial Disclosure |
- 1211. Conjunctival Squamous Papilloma
- (UMLS (NCI) C1333149) Squamous Cell Papilloma of Conjunctiva;
Squamous Cell Papilloma of the Conjunctiva;
=Neoplastic Process ;
| - 1261. Consent Form
- [A document explaining all relevant study information to assist the study volunteer in understanding the expectations and requirements of participation in a clinical trial. This document is presented to and signed by the study subject. (from centerwatch.com glossary) ( NCI )] (UMLS (NCI) C0009797) =Intellectual Product
|
- 1212. Conjunctival vascular disorders and cysts
- [ ] (UMLS (ICD9CM) C0155168) =Disease or Syndrome ;
| - 1262. Consent Identifier
- (UMLS (HL7) C1547797) =Intellectual Product =HL7 Vocabulary Version 2.5;
|
- 1213. CONJUNCTIVAL XEROSIS
- [dryness of the eye surfaces caused by deficiency of tears or conjunctival secretions; may be associated with vitamin A deficiency, trauma, or any condition in which the eyelids do not close completely. ( CSP )] (UMLS (ICD9CM) C0043349) =Disease or Syndrome =CONJUNCTIVA DISORDER NOS;
Dry Eye Syndrome;
Disorder of eye, unspecified;
| - 1263. Consent Mode
- (UMLS (HL7) C1547873) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Written;
Telephone;
Verbal |
- 1214. conjunctivitis
- [inflammation of the mucous membrane that lines the inner surface of the eyelids and the anterior part of the sclera; also called pinkeye and redeye. ( CSP )] (UMLS (CSP) C0009763) =Disease or Syndrome =CONJUNCTIVA DISORDER NOS;
Disorder of eye, unspecified =Conjunctivitis, Inclusion;
keratoconjunctivitis;
Fiessinger Leroy Reiter syndrome;
allergias conjunctivitis;
Bacterial Conjunctivitis;
Conjunctivitis, Viral;
keratoconjunctivitis;
Fiessinger Leroy Reiter syndrome;
| - 1264. Consent Non-Disclosure Reason
- (UMLS (HL7) C1547876) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Patient Request;
Rx Private;
Emergency |
- 1215. Conjunctivitis due to toxoplasmosis
- [ ] (UMLS (ICD9CM) C0153307) =Disease or Syndrome
| - 1265. Consent Status
- (UMLS (HL7) C0586888) =Functional Concept =HL7 Vocabulary Version 2.5;
=Active _ Consent has been granted;
Bypassed (Consent not sought);
Limited _ Consent has been granted with limitations;
Pending _ Consent has not yet been sought;
Refused _ Consent has been refused;
Rescinded _ Consent was initially granted, but was subsequently revoked or ended.;
|
- 1216. Conjunctivitis in mucocutaneous disease
- [ ] (UMLS (ICD9CM) C0155153) =Disease or Syndrome
| - 1266. Consent Type
- (UMLS (HL7) C1547872) =Health Care Activity =HL7 Vocabulary Version 2.5;
=Release of Information/MR / Authorization to Disclosure Protected Health Information;
Medical Procedure (invasive);
Acknowledge Receipt of Privacy Notice;
Abortion;
Abortion/Laminaria;
Accutane _ Information;
Accutane _ Woman;
Advanced Beneficiary Notice;
AFP (Alpha Fetoprotein) Screening;
Amniocentesis (consent & refusal);
Anatomical Gift (organ donation);
Anesthesia - Complications;
Anesthesia - Questionnaire;
Angiogram;
Angioplasty;
Anticancer Drugs;
Antipsychotic Medications;
Arthrogram;
Autopsy;
AZT More… |
- 1217. CONJUNCTIVITIS NEC
- [ ] (UMLS (ICD9CM) C0029560) =Disease or Syndrome ;
| - 1267. Conservator
- (UMLS (HL7) C1549087) =Idea or Concept =Signatory_s Relationship to Subject;
|
- 1218. Conjunctivitis, giant papillary
- (UMLS (NCI) C0009769) =Disease or Syndrome
| - 1268. Consistency
- (UMLS (HL7) C1547017) =Quantitative Concept =Kind of quantity;
|
- 1219. CONJUNCTIVOCHALASIS
- [ ] (UMLS (ICD9CM) C0878693) =Disease or Syndrome
| - 1269. CONSL PARTNER PROB
- [ ] (UMLS (ICD9CM) C0375880) =Finding
|
- 1220. CONJUNCTIVOCYSTORHINOST
- (UMLS (ICD9CM) C1533173) Conjunctivocystorhinostomy;
=Therapeutic or Preventive Procedure ;
| - 1270. CONSLN OT SEX TRNSMT DIS
- [ ] (UMLS (ICD9CM) C0375890) =Finding
|
- 1221. Conjunctivoplasty
- [ ] (UMLS (ICD9CM) C0197254) =Therapeutic or Preventive Procedure
| - 1271. CONST APLASTC ANEMIA NEC
- [ ] (UMLS (ICD9CM) C1719322) Other constitutional aplastic anemia =Disease or Syndrome
|
- 1222. CONJUNCTIVOPLASTY NEC
- [ ] (UMLS (ICD9CM) C0176202) =Therapeutic or Preventive Procedure
| - 1272. CONSTANT EXOPHTHALMOS
- [ ] (UMLS (ICD9CM) C0155267) =Disease or Syndrome ;
|
- 1223. CONJUNCTIVORHINOS W TUBE
- [ ] (UMLS (ICD9CM) C0176191) =Therapeutic or Preventive Procedure
| - 1273. constant region gene
- [ ] (UMLS (CSP) C0598659) =Gene or Genome
|
- 1224. CONN'S SYNDROME
- [overproduction of aldosterone by an adrenal cortical adenoma, characterized typically by low potassium levels, underacidity of the body, muscular weakness, excess urination, excess thirst, and high blood pressure. ( CSP )] (UMLS (ICD9CM) C1384514) primary hyperaldosteronism =Disease or Syndrome ;
=Hyperaldosteronism;
syndrome | - 1274. Constant-T
- (UMLS (NCI) C0700845) =Organic Chemical; Pharmacologic Substance
|
- 1225. Connaught
- (UMLS (HL7) C0331947) =Health Care Related Organization =Manufacturers of Vaccines (code=MVX);
| - 1275. Constipation
- [condition in which bowel movements are infrequent or incomplete.(CSP)] (UMLS (ICPC) C0009806) (Constipation; ESTITIKEZA; Obstipation; Obstipatie; UMMETUS; Constipation; Verstopfung/Obstipation; atzirut; szekrekedes; Stipsi; TREG MAGE/FORSTOPPELSE/OBSTIPASJON k59.0; Obstipacao; Estrenimiento; FORSTOPPNING) =Sign or Symptom =Body System, Gastrointestinal; Intestinal Diseases; gastrointestinal sign/symptom; Symptoms and Complaints Component
|
- 1226. Connaught [Inactive - use PMC]
- [Connaught [Inactive-use PMC] ( HL7V3.0 )] (UMLS (HL7) C1552889) =Health Care Related Organization =VaccineManufacturer;
| - 1276. CONSTIPATION NEC
- [ ] (UMLS (ICD9CM) C0949135) Other constipation =Disease or Syndrome
|
- 1227. Connecticut
- [A state in the northeastern United States. Its capital is Hartford. ( NCI )] (UMLS (NCI) C0009778) =Geographic Area
| - 1277. CONSTIT STATE IN DEV NEC
- [ ] (UMLS (ICD9CM) C0260548) =Finding
|
- 1228. Connective and Soft Tissue Cell
- [group of cells that includes fibroblasts, cartilage cells, adipocytes, smooth muscle cells, and bone cells. ( CSP )] (UMLS (NCI) C0009781) =Cell = ;
=fibroblast;
Mast Cell;
odontoblast;
osteoblast;
osteoclast;
osteocyte;
stromal cell;
adipocyte;
chondrocyte | - 1278. CONSTIT STATE IN DEV NOS
- [ ] (UMLS (ICD9CM) C0260549) =Finding
|
- 1229. Connective and Soft Tissue Disease
- [Any deviation from the normal structure or function of the musculoskeletal or connective tissue that is manifested by a characteristic set of symptoms and signs. (NCI) ( NCI )] (UMLS (NCI) C1333150) Connective and Soft Tissue Diseases;
Connective and Soft Tissue Disorder;
MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS =Disease or Syndrome ;
| - 1279. CONSTITUTION RBC APLASIA
- [ ] (UMLS (ICD9CM) C1719319) Constitutional red blood cell aplasia =Disease or Syndrome
|
- 1230. Connective and Soft Tissue Finding
- (UMLS (NCI) C1333151) =Finding ;
| - 1280. Constitutional Finding
- (UMLS (NCI) C0009812) =Sign or Symptom
|
- 1231. Connective and Soft Tissue Neoplasm
- [A benign or malignant, primary or metastatic tumor affecting soft tissues or bone. Representative examples include mesenchymal cell neoplasms, metastatic carcinomas to the bones, and primary neoplasms of uncertain histogenesis. ( NCI )] (UMLS (NCI) C0206765) =Neoplastic Process =Neoplasms by Histologic Type;
=connective tissue cancer;
Neoplasms, Muscle Tissue;
Adipose Tissue Neoplasm;
Connective Tissue Sarcoma | - 1281. Constitutional states in development
- [ ] (UMLS (ICD9CM) C0260546) =Finding
|
- 1232. connective tissue
- [tissue that supports and binds other tissues; consists of connective tissue cells embedded in a large amount of extracellular matrix. ( CSP )] (UMLS (CSP) C0009780) =Tissue =Normal Tissue;
=adipose fat body;
cartilage;
elastic tissue;
periosteum;
tendon;
mesenchyme;
connective tissue stroma | - 1282. CONSTRICTIV PERICARDITIS
- [Inflammation of the PERICARDIUM that is characterized by the fibrous scarring and adhesion of both serous layers, the VISCERAL PERICARDIUM and the PARIETAL PERICARDIUM leading to the loss of pericardial cavity. The thickened pericardium severely restricts cardiac filling. Clinical signs include FATIGUE, muscle wasting, and WEIGHT LOSS. ( MSH )] (UMLS (ICD9CM) C0031048) =Disease or Syndrome =pericarditis;
|
- 1233. connective tissue cancer
- [new abnormal connective tissue that grows by excessive cellular division and proliferation more rapidly than normal and continues to grow after the stimuli that initiated the new growth cease; refers to neoplasms located in the connective tissue as well as those consisting of connective tissue. ( CSP )] (UMLS (CSP) C0027656) =Neoplastic Process ;
=Connective Tissue Disease;
Connective and Soft Tissue Neoplasm;
neoplasm/cancer site;
neoplasm/cancer type =Fibroma;
Fibrosarcoma;
angiosarcoma;
Liposarcoma;
mesenchymoma;
cartilage cancer;
histiocytoma;
chondroblastoma;
chondrosarcoma;
Giant Cell Neoplasm;
Angiomyxoma;
Myxosarcoma;
Sarcoma, Synovial;
Neoplasms, Bone Tissue;
Fibrocytic Neoplasm;
Clear Cell Sarcoma of Soft Parts;
Sarcoma, Small Cell;
Chondroma;
| - 1283. Construct
- [DNA artificially constructed by combining genes from different organisms or by cloning chemically altered DNA, usually for the purpose of genetic manipulation. ( CSP )] (UMLS (NCI) C0012931) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
=deoxyribonucleic acid;
genetic manipulation |
- 1234. connective tissue development
- [ ] (UMLS (CSP) C0596374) =Organism Function =growth/development;
=bone development;
fibrogenesis;
cartilage development;
| - 1284. CONSTRUCTION EAR AURICLE
- [ ] (UMLS (ICD9CM) C0176322) =Therapeutic or Preventive Procedure
|
- 1235. Connective Tissue Disease
- [deviation from or interruption of the normal structure or function of the connective tissue. ( CSP )] (UMLS (NCI) C0009782) =Disease or Syndrome =Disease;
Skin and Connective Tissue Diseases =Cartilage Diseases;
cicatrix;
Collagen Diseases;
chalastodermia;
dermatosclerosis;
disseminated lupus erythematosus;
connective tissue cancer;
Musculoskeletal Pain Disorder;
Buschke's scleredema;
polymyositis;
connective tissue hyperplasia;
Cartilage Diseases;
cellulitis;
Collagen Diseases;
chalastodermia;
dermatomyositis;
CONTRACTED PALMAR FASCIA;
cystathionine synthase deficiency;
Cutaneous Lupus Erythematosus;
disseminated lupus erythematosus;
Marfan syndrome;
Mixed Connective Tissue Disease;
connective tissue cancer;
Noonan Syndrome;
OSTEOPOIKILOSIS;
Panniculitis;
Penile Fibromatosis;
pseudoxanthoma elasticum;
Musculoskeletal Pain Disorder;
CIRCUMSCRIBE SCLERODERMA;
progressive systemic sclerosis;
Mucinoses;
alpha 1 antitrypsin deficiency | - 1285. CONSTRUCTION OF PENIS
- [ ] (UMLS (ICD9CM) C0177142) =Therapeutic or Preventive Procedure
|
- 1236. connective tissue disorder chemotherapy
- [application of the beneficial effects of drugs to control or cure diseases of tissues that support and bind other tissues. ( CSP )] (UMLS (CSP) C0596375) =Therapeutic or Preventive Procedure =chemotherapy;
connective tissue disorder therapy | - 1286. Consult
- [A conference between two or more people to consider a particular question; the act of deliberating together; confering with another researcher, physician, or expert about an issue or a case. ( NCI )] (UMLS (NCI) C0009818) =Health Care Activity
|
- 1237. connective tissue disorder diagnosis
- [determination of diseases of the tissues that support or bind other tissues based on symptoms, medical history, risk factors, and clinical tests. ( CSP )] (UMLS (CSP) C0596376) =Diagnostic Procedure =Diagnosed;
| - 1287. Consult between primary care providers
- (UMLS (ICPC) C0497107) (Consult between primary care providers; ko beste agente batekin koordinazioa(elkarkontsulta); Samrad med anden s-arb i primst; Overleg binnen eerste lijn; PERUSTERVEYDENHUOLLON ASIANTUNTIJAN KONSULTAATIO; Discussion entre dispensateurs SSP; Gespraech Mitarbeiter Primaerversorg; (108); alapellatason beluli konzultacio; Consulto tra operat sanit di base; KONTAKT HELSEARB/PRIMAERHELSETJ; Consulta entre prestadores de csp; Interconsulta entre medicos a.p.; KONSULTATION MED PERSON INOM PRIMARVARDEN) Consult between prim care provid =Health Care Activity =Diagnostic and Preventive Procedures Component;
|
- 1238. connective tissue disorder therapy
- [therapies alone or in any combination, such as relaxation, exercise, massage, ultrasound, surgery, or alternative medicine; for drug therapies use CONNECTIVE TISSUE DISORDER CHEMOTHERAPY. ( CSP )] (UMLS (CSP) C0872028) =Therapeutic or Preventive Procedure ;
=Therapeutic Interventions;
=connective tissue disorder chemotherapy | - 1288. Consult provider with specialist
- (UMLS (ICPC) C0497108) (Consult provider with specialist; espezialista batekin koordinazioa; Kollegialt samrad speciallaege; Overleg met specialist; ERIKOISSAIRAANHOIDON ASIANTUNTIJAN KONSULTAATIO; Discussion dispensateur/specialiste; Gespraech des Arztes mit Facharzt; (108); szakorvosi konzultacio; Consulto di oper con specialista; KONTAKT MED SPESIALIST; Cons do prestador com especialista; Interconsulta con especialista; SPECIALISTKONSULTATION) =Health Care Activity =Diagnostic and Preventive Procedures Component;
|
- 1239. Connective Tissue Fiber
- (UMLS (NCI) C0230895) =Body Substance
| - 1289. Consultant
- [An advisor participating in the service by performing evaluations and making recommendations. ( HL7V3.0 )] (UMLS (HL7) C1549076) =Idea or Concept =Institution Relationship Type;
ParticipationAncillary |
- 1240. connective tissue growth factor
- [cysteine rich mitogen secreted by vascular endothelial cells. ( CSP )] (UMLS (CSP) C0110610) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=Growth Agents;
immediate early protein | - 1290. Consultation
- (UMLS (HL7) C1546898) =Classification =Diagnosis Classification;
◊ (UMLS (HL7) C1548374) Intellectual Product ; Document; |
- 1241. Connective Tissue Growth Factor Gene
- [This gene is involved in mitogenesis. ( NCI )] (UMLS (NCI) C1413791) CTGF;
CTGF Gene =Gene or Genome | - 1291. CONSULTATION NEC
- [ ] (UMLS (ICD9CM) C0177812) =Health Care Activity
|
- 1242. Connective Tissue Growth Factor Related Protein WISP-3
- [Encoded by human oncogene WISP3 Gene (CCN Family), the 354-amino acid 39.3 kD WNT1 Inducible Signaling Pathway Protein 3 constitutes - with WISP1 and WISP2 - one of three factors downstream in the WNT signaling pathway relevant to malignant transformation. CCN proteins are cell- and tissue-specific cysteine-rich secreted factors with roles in cell growth and differentiation. WISP3 protein is essential for skeletal growth and cartilage homeostasis; mutations are associated with progressive pseudorheumatoid dysplasia. WISP3 is over expressed in colon tumors. (OMIM, Swiss-Prot, LocusLink, and NCI) ( NCI )] (UMLS (NCI) C1309276) WISP3;
WISP3 Protein;
WNT1 Inducible Signaling Pathway Protein 3 =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 1292. Consultation, described as limited
- (UMLS (ICD9CM) C0199177) =Health Care Activity
|
- 1243. connective tissue hyperplasia
- [abnormal increase in the number of otherwise normal cells in connective tissue without tumor formation that leads to enlargement of the connective tissue; it differs from hypertrophy, which is an increase in bulk without an increase in the number of cells. ( CSP )] (UMLS (CSP) C0596377) =Disease or Syndrome =Connective Tissue Disease;
hyperplasia | - 1293. Consulted Other Source
- [Consulted other supply source, therapy still appropriate ( HL7V3.0 )] (UMLS (HL7) C1555291) =Intellectual Product =Therapy Appropriate;
|
- 1244. connective tissue metabolism
- [sum of chemical changes that occur within the connective tissues consisting of anabolism (biosynthesis) and catabolism; the buildup and breakdown of molecules for utilization by the connective tissues. ( CSP )] (UMLS (CSP) C0596378) =Organ or Tissue Function =Intermediary Metabolism;
=cartilage metabolism;
| - 1294. Consulted Prescriber
- [Consulted prescriber, therapy confirmed ( HL7V3.0 )] (UMLS (HL7) C1555292) =Idea or Concept =Therapy Appropriate;
=Prescriber Declined Change;
|
- 1245. connective tissue pharmacology
- [study of the origin, nature, properties, and actions of drugs and their effects on connective tissue; use this term mainly for intended, desired effects. ( CSP )] (UMLS (CSP) C0596379) =Biomedical Occupation or Discipline =Pharmacologic;
| - 1295. Consulted Supplier
- [Consulted other supplier/pharmacy, therapy confirmed ( HL7V3.0 )] (UMLS (HL7) C1555556) =Intellectual Product =Therapy Appropriate;
|
- 1246. Connective Tissue Sarcoma
- [any of a group of tumors usually arising from connective tissue, although the term now includes some of epithelial origin; most are malignant. ( CSP )] (UMLS (NCI) C1261473) Malignant Neoplasm of Soft Tissue;
Malignant Neoplasm of the Soft Tissue;
Malignant Soft Tissue Neoplasm;
Malignant Soft Tissue Tumor;
Malignant Tumor of Soft Tissue;
Malignant Tumor of the Soft Tissue;
Sarcoma;
Sarcoma of Soft Tissue;
Sarcoma of Soft Tissue and Bone;
Sarcoma of the Soft Tissue;
Sarcoma of the Soft Tissue and Bone;
Soft Tissue Sarcoma =Neoplastic Process ;
=Connective and Soft Tissue Neoplasm;
neoplasm/cancer type =carcinosarcoma;
Fibrosarcoma;
angiosarcoma;
Leiomyosarcoma;
Liposarcoma;
nephroblastoma;
Osteogenic Sarcoma;
rhabdomyoblastoma;
HHV 8;
Lymphoma, Diffuse;
avian leukosis/sarcoma;
Ewing Family of Tumors;
Adenosarcoma;
carcinosarcoma;
chondrosarcoma;
cystosarcoma phyllodes;
Fibrosarcoma;
angiosarcoma;
Leiomyosarcoma;
Liposarcoma;
Lymphangioendothelial Sarcoma;
Myosarcoma;
Myxosarcoma;
Osteogenic Sarcoma;
Sarcoma, Experimental;
HHV 8;
Sarcoma, Synovial;
Mixed Tumor, Mesodermal;
Endometrial Stromal Sarcoma;
Clear Cell Sarcoma of Soft Parts;
Sarcoma, Small Cell;
Alveolar Soft Part Sarcoma | - 1296. Consulting Provider
- (UMLS (HL7) C1548440) =Idea or Concept =Provider role;
|
- 1247. connective tissue stroma
- [supporting tissue or matrix of an organ as distinguished from its functional elements. ( CSP )] (UMLS (CSP) C0596380) =Tissue =connective tissue;
| - 1297. consumable
- [Target that is taken up, is diminished, and disappears in the service. ( HL7V3.0 )] (UMLS (HL7) C1550507) =Idea or Concept =direct target;
=therapeutic agent |
- 1248. connexin
- [A group of homologous proteins which form the intermembrane channels of GAP JUNCTIONS. The connexins are the products of an identified gene family which has both highly conserved and highly divergent regions. The variety contributes to the wide range of functional properties of gap junctions. ( MSH )] (UMLS (CSP) C0110611) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 1298. consumable biomedical equipment
- [ ] (UMLS (CSP) C0920447) =Medical Device
|
- 1249. connexon
- [ ] (UMLS (CSP) C0230609) =Cell Component
| - 1299. consumable/disposable biomedical equipment
- [laboratory, clinical or biomedical instruments or products that have limited time use; will be thrown away or used up; coordinate indexing with specific instrument. ( CSP )] (UMLS (CSP) C0872029) =Medical Device ;
=Medical Devices;
|
- 1250. conotoxin
- [peptide neurotoxin from marine snails of genus Conus. ( CSP )] (UMLS (CSP) C0304176) =Amino Acid, Peptide, or Protein; Biologically Active Substance; Hazardous or Poisonous Substance =marine toxin;
Neurotoxin | - 1300. consumer product
- [goods for personal use that directly satisfy human wants, needs, or desires. ( CSP )] (UMLS (CSP) C0596381) =Qualitative Concept =Material;
=[OR500] MOUTHWASHES;
TOBACCO;
water supply;
|
home
